Dr. David Berz
Claim this profileValkyrie Clinical Trials
Area of expertise
Lung Cancer
David Berz has run 10 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
David Berz has run 7 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Valkyrie Clinical Trials
Beverly Hills Cancer Center
Clinical Trials David Berz is currently running
Zotatifin
for Solid Tumors
This trial is testing a new drug called Zotatifin for patients with advanced cancers that haven't improved with standard treatments. The drug works by stopping cancer cells from making essential proteins, which may slow or stop the cancer.
Recruiting
3 awards
Phase 1 & 2
21 criteria
H002
for Non-Small Cell Lung Cancer
This is a phase I/IIa, open-label, dose-escalation and expansion study to evaluate the safety, tolerability, PK and preliminary anti-tumor activity of H002 when given orally in patients with active EGFR mutation locally advanced or metastatic non-small cell lung cancer (NSCLC). The study will contain two parts: Part A is dose escalation phase (i.e., Phase I) and Part B is dose expansion phase (i.e., Phase IIa).
Recruiting
1 award
Phase 1 & 2
12 criteria
More about David Berz
Clinical Trial Related
3 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments David Berz has experience with
- Trilaciclib
- Capecitabine
- Docetaxel
- Pembrolizumab
- H002
- BMS-986466
Breakdown of trials David Berz has run
Lung Cancer
Non-Small Cell Lung Cancer
- BDTX-1535 + Temozolomide for Glioblastoma and Lung Cancer
- Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4)
- Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
Solid Tumors
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Berz specialize in?
David Berz focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is David Berz currently recruiting for clinical trials?
Yes, David Berz is currently recruiting for 5 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that David Berz has studied deeply?
Yes, David Berz has studied treatments such as Trilaciclib, Capecitabine, Docetaxel.
What is the best way to schedule an appointment with David Berz?
Apply for one of the trials that David Berz is conducting.
What is the office address of David Berz?
The office of David Berz is located at: Valkyrie Clinical Trials, Los Angeles, California 90067 United States. This is the address for their practice at the Valkyrie Clinical Trials.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.